DTIC (NSC-45388) in malignant melanoma: a perspective

Cancer Treat Rep. 1976 Feb;60(2):165-76.
No abstract available

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Carmustine / therapeutic use
  • Clinical Trials as Topic
  • Dacarbazine / therapeutic use*
  • Drug Evaluation
  • Drug Therapy, Combination
  • Humans
  • Lomustine / therapeutic use
  • Melanoma / drug therapy*
  • Melanoma / mortality
  • Mice
  • Neoplasm Metastasis
  • Nitrosourea Compounds / therapeutic use
  • Remission, Spontaneous
  • Triazenes / therapeutic use*

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Triazenes
  • Lomustine
  • Dacarbazine
  • Carmustine